Rosetta Capital (UK) Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 5
Professionals
  • Investments
  • 63
  • Portfolio
  • 22
  • Exits
  • 40
Exits

Rosetta Capital (UK) General Information

Description

Founded in 2001, Rosetta Capital is a venture capital firm headquartered in Buckinghamshire, United Kingdom. The firm seeks to invest in companies operating in the life science, medical technology sectors and specializes in acquiring secondary direct portfolios.

Contact Information

Year Founded
2001
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Primary Office
  • Rectory House, Thame Road
  • Haddenham, Aylesbury
  • Buckinghamshire HP17 8DA
  • England, United Kingdom
+44 01844 000000

Rosetta Capital (UK) Investments (63)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Carrick Therapeutics 15-Mar-2021 Secondary Transaction - Private Therapeutic Devices Generating Revenue 00000000 000000 00.0
0000000 15-Mar-2021 000000000 00 Diagnostic Equipment Generating Revenue 00000000 000000 00.0
00000 000000000 15-Mar-2021 000000000 00 Drug Discovery Generating Revenue 00000000 000000 00.0
00000000 00000 15-Mar-2021 000000000 00 Drug Discovery Generating Revenue/Not Profitable
0000000 0000000000 27-Jan-2021 000000000 00 Drug Discovery Generating Revenue
0000000 0000000000 27-Jan-2021 000000000 00 000.00 Biotechnology Clinical Trials - General
0000000000 01-Jan-2021 000000000 00 Drug Discovery Generating Revenue/Not Profitable
00000 000000000000 02-Oct-2017 00000 00000 000.00 Drug Discovery Clinical Trials - General 00000000 000000 00.0
Promore Pharma 06-Jul-2017 IPO 000.00 Biotechnology Generating Revenue/Not Profitable
Kuur Therapeutics 16-Mar-2017 Later Stage VC 0000 Drug Discovery Clinical Trials - General
You’re viewing 10 of 63 investments. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Rosetta Capital (UK) Exits (40)

Company Name Exit Date Exit Type Exit Size
Kuur Therapeutics 04-May-2021 Merger/Acquisition 0000
0000000000 05-Feb-2021 000 00000
00000 000000000000 03-Oct-2019 000 0000
0000000 000000 24-Sep-2018 000 000.00
00000000 15-May-2018 000 00000
0000000 000000 04-Sep-2017 000 000.00
0000000 00000 20-Apr-2017 0000000000
000 000000000000 21-Feb-2017 000000000000000000 00000
FF Pharma 01-Sep-2016 Out of Business
Delenex Therapeutics 12-Jul-2016 Merger/Acquisition
You’re viewing 10 of 40 exits. Get the full list »

Rosetta Capital (UK) Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Rosetta Capital (UK) Team (7)

Name Title Deals Funds Boards Office
Michael Forer Co-Founder & Partner 0 Buckinghamshire, United Kingdom
Graham Fagg Ph.D Partner 0 0 0 Buckinghamshire, United Kingdom
Jonathan Hepple Ph.D Co-Founder and Partner 0 0 0 Buckinghamshire, United Kingdom
Donald Macpherson Partner and Non-Executive Chairman 0 Buckinghamshire, United Kingdom
Torsten Goesch Ph.D Partner 0 0 0 Buckinghamshire, United Kingdom
You’re viewing 5 of 7 team members. Get the full list »

Rosetta Capital (UK) Co-Investors (12)

Name With Exits Lead Partner Series Industry
Karolinska Development 2 0 Series chart Industry bar
5AM Ventures 0 0 Series chart Industry bar
HealthCap 0 0 Series chart Industry bar
IP Group 0 0 0 Series chart Industry bar
Versant Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 12 co-investors. Get the full list »